Abstracts
Deadline for abstract submission: March 15th 2025
Participants are invited to present the outcome of their research at the 17th EMGM Congress 2025. Abstracts should be submitted via this website only. Abstracts submitted via fax or e-mail will not be accepted.
Click here to download an abstract sample
Abstracts must describe original, previously unpublished work. All abstracts must be submitted and presented in clear English with accurate grammar and spelling of a quality suitable for publication.
Instructions for submitting the abstracts:1) General style and format:
Oral communication or Poster presentation
Font: Arial
Font size: 11
Text alignment: Justify
Line spacing: single
Maximum of 250 words per abstract
2) Abstract Title:
3) Author name(s) and affiliation(s):
First Name(s): Initials of the first name followed by a dot
Last name: Sentence case
Affiliation(s): Sentence case
An affiliation should consist at least of a country name
4) Please use open lines between paragraphs
5) Headings:
You may use headings, if applicable.
Please use boldface for headings and put the colon in bold too.
If the headings comprise multiple entities, use a starting capital for each entity (e.g. Material and Methods:). If the heading comprises multiple words but only one entity, only the first word has a capital (e.g. Preliminary results:).
If there are subheadings, please use italics for those.
7) No graphs/tables/images are allowed.
- Epidemiology of IMD and IHiD in the EMGM countries
- Clinical aspects and management of IMD and IHiD (clinical presentations, diagnostics, treatment and sequelae, management of contacts)
- Antibiotic resistance (Nm and Hi)
- Strain molecular characterization
- Recent outbreaks
- Vaccines and vaccination policies
There is no option to save the abstract as draft and to submit it at a later stage. If you do not submit your abstract, the information will be deleted.
Abstracts must be received by the announced deadline. Abstracts received after the deadline will not be considered.
The presenting author is required to ensure that all co-authors are aware of the content of the abstract before submission of his/her abstract.
The Committee will endeavor to schedule abstracts according to authors’ preferences but reserves the right to decide on the final form of presentation.
All abstracts will be forwarded to the Scientific Committee for review. Notifications regarding status will be sent once the review process is complete.
The Scientific Committee will determine whether abstracts will be accepted as oral or poster presentations, with consideration to be given to the author’s preference.
The presenting author is expected to attend and register for the 17th EMGM Congress 2025 by the communicated registration deadline and present the poster or oral presentation.
Submission of the abstract constitutes the author’s consent to publication (e.g. congress website, programs, other promotions, etc.
After submission you will be sent a confirmation via e-mail that your abstract has been received. If you do not receive the confirmation e-mail within five (5) working days of your submission, please contact the Meeting Secretariat at Lparissi@free-spirit.gr
Secretarial support
12 Thessalonikis Str., 15344 Gerakas, Athens, Greece
Tel : +30-210 6048 260
Fax: +30-210 6047 457
E-mail: Lparissi@free-spirit.gr
Website: www.free-spirit.gr